Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ISBA
|
Julie Huber
VP & Chief Technology Officer |
BUY
Open market or private purchase
|
Direct | 9 Added 8.91% |
$138
$15.29 p/Share
|
Nov 02
2020 |
|
ISBA
|
Gregory S Matthews
Chief Credit Officer |
BUY
Open market or private purchase
|
Direct | 9 Added 2.07% |
$138
$15.29 p/Share
|
Nov 02
2020 |
|
ISBA
|
Rhonda S Tudor
Controller |
BUY
Open market or private purchase
|
Direct | 9 Added 3.3% |
$138
$15.29 p/Share
|
Nov 02
2020 |
|
MYFW
|
Joseph C. Zimlich
Director |
BUY
Open market or private purchase
|
Direct | 2,878 Added 8.24% |
$41,702
$14.49 p/Share
|
Nov 02
2020 |
|
CYDY
|
Jordan G Naydenov
Director |
BUY
Open market or private purchase
|
Direct | 193,500 Added 2.91% |
$497,295
$2.57 p/Share
|
Nov 02
2020 |
|
PHAT
|
Azmi Nabulsi
Chief Operating Officer |
SELL
Open market or private sale
|
Indirect | 14,500 Reduced 1.67% |
$534,035
$36.83 p/Share
|
Nov 02
2020 |
|
QUOT
|
Mc Kenna Michelle
Director |
SELL
Open market or private sale
|
Direct | 2,216 Reduced 4.18% |
$19,811
$8.94 p/Share
|
Nov 02
2020 |
|
EGY
|
David Des Autels
Executive VP, Corp. Dev. |
SELL
Payment of exercise price or tax liability
|
Direct | 3,273 Reduced 2.2% |
$2,684
$0.82 p/Share
|
Nov 02
2020 |
|
ARCT
|
Pad Chivukula
Chief Scientific Officer & COO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 1.4% |
$552,800
$55.28 p/Share
|
Nov 02
2020 |
|
EZPW
|
Jason A. Kulas
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 0.76% |
$4,520
$4.52 p/Share
|
Nov 02
2020 |
|
CPSI
|
John B Douglas Jr |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.42% |
$27,820
$27.82 p/Share
|
Nov 02
2020 |
|
CPSI
|
David A Dye
Director |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.33% |
$27,800
$27.8 p/Share
|
Nov 02
2020 |
|
TCX
|
Elliot Noss
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 0.91% |
$371,450
$74.29 p/Share
|
Nov 02
2020 |
|
BBBY
|
Harriet Edelman
Director |
BUY
Open market or private purchase
|
Direct | 7,500 Added 21.23% |
$149,550
$19.94 p/Share
|
Nov 02
2020 |
|
SRLP
|
Paul A. Scoff
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 200 Added 1.29% |
$3,228
$16.14 p/Share
|
Nov 02
2020 |
|
SRLP
|
Paul A. Scoff
Officer |
SELL
Open market or private sale
|
Direct | 1,702 Reduced 10.17% |
$27,436
$16.12 p/Share
|
Nov 02
2020 |
|
RLMD
|
Charles J Casamento
Director |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 5.75% |
$90,870
$30.29 p/Share
|
Nov 02
2020 |
|
RAPT
|
William Ho
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.54% |
$28,060
$28.06 p/Share
|
Nov 02
2020 |
|
RAPT
|
Karen C Lam
VP, Finance and Controller |
SELL
Open market or private sale
|
Direct | 2,022 Reduced 13.7% |
$56,899
$28.14 p/Share
|
Nov 02
2020 |
|
RAPT
|
Dirk G. Brockstedt
CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct | 1,910 Reduced 15.7% |
$53,595
$28.06 p/Share
|
Nov 02
2020 |
|
DGICA
|
Dennis Joseph Bixenman
Director |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 67.97% |
$169,680
$14.14 p/Share
|
Nov 02
2020 |
|
DGICA
|
Dennis Joseph Bixenman
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 12,000 Added 40.47% |
$150,000
$12.5 p/Share
|
Nov 02
2020 |
|
NTGR
|
Tamesa Rogers
Chief People Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 6.71% |
$94,680
$31.56 p/Share
|
Nov 02
2020 |
|
NTGR
|
Tamesa Rogers
Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,000 Added 6.3% |
$57,990
$19.33 p/Share
|
Nov 02
2020 |
|
QTRX
|
Amol Chaubal
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 116 Reduced 0.46% |
$4,289
$36.97 p/Share
|
Nov 02
2020 |
|
QTRX
|
John J Fry
General Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 142 Reduced 0.45% |
$5,250
$36.97 p/Share
|
Nov 02
2020 |
|
QTRX
|
Dawn Mattoon
Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct | 159 Reduced 0.5% |
$5,878
$36.97 p/Share
|
Nov 02
2020 |
|
QTRX
|
Mark T. Roskey
SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct | 91 Reduced 0.43% |
$3,364
$36.97 p/Share
|
Nov 02
2020 |
|
YEXT
|
Steven Cakebread
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 25.93% |
$164,000
$16.4 p/Share
|
Nov 02
2020 |
|
YEXT
|
Steven Cakebread
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 20.59% |
$61,100
$6.11 p/Share
|
Nov 02
2020 |
|
FLWS
|
Christopher G Mccann
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 20,383 Reduced 1.89% |
$420,705
$20.64 p/Share
|
Nov 02
2020 |
|
JOUT
|
Thomas F Pyle Jr
Director |
SELL
Open market or private sale
|
Direct | 2,981 Reduced 5.61% |
$259,735
$87.13 p/Share
|
Nov 02
2020 |
|
SWBI
|
Michael F Golden
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.52% |
$174,000
$17.4 p/Share
|
Nov 02
2020 |
|
SWBI
|
Michael F Golden
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 3.4% |
$21,500
$2.15 p/Share
|
Nov 02
2020 |
|
CDLX
|
Scott D. Grimes
Director |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.61% |
$151,420
$75.71 p/Share
|
Nov 02
2020 |
|
CCF
|
Adam Chase
President/CEO |
SELL
Open market or private sale
|
Indirect | 1,250 Reduced 0.63% |
$121,625
$97.3 p/Share
|
Nov 02
2020 |
|
CDE
|
Robert E Mellor
Director |
BUY
Open market or private purchase
|
Direct | 2,000 Added 1.13% |
$14,140
$7.07 p/Share
|
Nov 02
2020 |
|
FORR
|
Steven P. Peltzman
CBTO |
SELL
Open market or private sale
|
Direct | 2,710 Reduced 15.09% |
$103,414
$38.16 p/Share
|
Nov 02
2020 |
|
FORR
|
David Boyce |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 21.6% |
$75,500
$37.75 p/Share
|
Nov 02
2020 |
|
JRVR
|
Frank D'Orazio
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 62,669 Added 50.0% |
-
|
Nov 02
2020 |
|
SLP
|
Walter S Woltosz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 255 Added 0.01% |
$16,529
$64.82 p/Share
|
Nov 02
2020 |
|
PLAB
|
Christopher J Progler
EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 2.57% |
$29,580
$9.86 p/Share
|
Nov 02
2020 |
|
BANC
|
Mary A Curran |
BUY
Open market or private purchase
|
Indirect | 4,200 Added 15.64% |
$50,946
$12.13 p/Share
|
Nov 02
2020 |
|
BBIO
|
Michael Thomas Henderson
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.6% |
$386,300
$38.63 p/Share
|
Nov 02
2020 |
|
BBIO
|
Michael Thomas Henderson
Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 3.48% |
$10,500
$1.05 p/Share
|
Nov 02
2020 |
|
ELF
|
Tarang Amin
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 40,219 Reduced 5.1% |
$816,044
$20.29 p/Share
|
Nov 02
2020 |
|
ELF
|
Tarang Amin
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 46,077 Reduced 1.0% |
$945,961
$20.53 p/Share
|
Nov 02
2020 |
|
NG
|
Kalidas V Madhavpeddi |
SELL
Payment of exercise price or tax liability
|
Direct | 39,762 Reduced 17.31% |
$415,513
$10.45 p/Share
|
Nov 02
2020 |
|
NG
|
Kalidas V Madhavpeddi |
BUY
Exercise of conversion of derivative security
|
Direct | 109,700 Added 32.32% |
$415,763
$3.79 p/Share
|
Nov 02
2020 |
|
NG
|
Kalidas V Madhavpeddi |
SELL
Open market or private sale
|
Direct | 69,938 Reduced 36.81% |
$730,852
$10.45 p/Share
|
Nov 02
2020 |